Citation Impact
Citing Papers
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Rational Design of Intercellular Adhesion Molecule-1 (ICAM-1) Variants for Antagonizing Integrin Lymphocyte Function-associated Antigen-1-dependent Adhesion
2005 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
1997
A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity
1990 StandoutNobel
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inflammation and cancer
2002 StandoutNature
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations
1989
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
1996 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes.
1990
Passive Immunotherapy in the Treatment of Advanced Human Immunodeficiency Virus Infection
1993
The role of myeloid cells in the promotion of tumour angiogenesis
2008
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.
1998
Systemic Fluorescence Imaging of Zebrafish Glycans with Bioorthogonal Chemistry
2015 StandoutNobel
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
1996 StandoutNature
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
1991 Nature
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
1998 StandoutNature
CD8 + Cell Anti-HIV Activity: Nonlytic Suppression of Virus Replication
1992
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
2008
The Epigenomics of Cancer
2007 Standout
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
1993 StandoutNature
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer
2012
Antibody neutralization and escape by HIV-1
2003 StandoutNature
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
Immunity, Inflammation, and Cancer
2010 Standout
Epidemiology of Lung Cancer
2013
Histopathological predictors of regional lymph node metastasis at the invasive front in early colorectal cancer
2011
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
1995 StandoutNobel
Human Immunodeficiency Virus Type 1 Quasispecies In Vivo and Ex Vivo
1992
HIV as the cause of AIDS
1996 StandoutNobel
Cancer immunotherapy comes of age
2011 StandoutNature
Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy
1998
Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy
1998
Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infection
1991
Cytotoxic T Lymphocytes in Human Immunodeficiency Virus Infection: Responses to Structural Proteins
1994
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
2015
Changing Virus‐Host Interactions in the Course of HIV‐1 Infection
1994
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual.
1991
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
1995 StandoutNobel
Changes in thymic function with age and during the treatment of HIV infection
1998 StandoutNature
Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
1995
Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens
1993
Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human Macrophages
1993 StandoutScienceNobel
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
1996 StandoutScience
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
1996 StandoutScience
Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture
1991
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Imaging Cell Surface Glycosylation in Vivo Using “Double Click” Chemistry
2013
Cytotoxic T Lymphocyte Epitopes of HIV-1 Nef
2000
Misincorporation and mispaired primer extension by human immunodeficiency virus reverse transcriptase.
1994 StandoutNobel
Phenotypic Analysis of Antigen-Specific T Lymphocytes
1996 StandoutScience
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
1999 StandoutNobel
Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques
1998
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
1995 StandoutScience
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
1999 StandoutScience
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
2001 StandoutScience
Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes
1991
Inflammation, a Key Event in Cancer Development
2006
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.
1995 StandoutNobel
In vivo persistence of a HIV‐1‐encoded HLA‐B27‐restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity
1991
Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells
2003
Imaging bacterial peptidoglycan with near-infrared fluorogenic azide probes
2014 StandoutNobel
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
Pathogenesis of human immunodeficiency virus infection
1993
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
1994
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Viral dynamics in human immunodeficiency virus type 1 infection
1995 StandoutNature
Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
1993
Broad, Intense Anti-Human Immunodeficiency Virus (HIV) Ex Vivo CD8+Responses in HIV Type 1-Infected Patients: Comparison with Anti-Epstein-Barr Virus Responses and Changes during Antiretroviral Therapy
1999
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
1994 Standout
Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro
1991
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
1993 StandoutNobel
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
HIV replication in CD4+T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines
1996 StandoutNobel
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma.
1995 StandoutNobel
Alveolar macrophages from subjects infected with HIV-1 express macrophage inflammatory protein-1α (MIP-1α): contribution to the CD8+ alveolitis
1994
LAV Revisited: Origins of the Early HIV-1 Isolates from Institut Pasteur
1991 StandoutScienceNobel
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
1994 Standout
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Works of C Mayaud being referenced
Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes.
1988
HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-infected patients
1990
Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
1992
Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor Prolong the Survival of Neutrophils Infiltrating Bronchoalveolar Subtype Pulmonary Adenocarcinoma
2001
Upregulation of bronchioloalveolar carcinoma-derived C-X-C chemokines by tumor infiltrating inflammatory cells
2004
A lectin‐binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity
1991
Lung cancer in HIV infected patients: facts, questions and challenges
2006
HIV-specific cytotoxic T lymphocytes against alveolar macrophages: specificities and downregulation
1991
Human Immunodeficiency Virus-related Lymphocytic Alveolitis
1988
HIV-1 Infection of Lung Alveolar Fibroblasts and Macrophages in Humans
1990
Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes.
1989
Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome.
1998
Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV.
1997
Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.
1989